← Leaderboards
Gregory J. Aune
University Of Texas Hlth Science Center
$387,601
Attributed
$775,201
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $218.7K · FY2015–22$250K$187.5K$125K$62.5K$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$775,201 · 2
By mechanism
R21$775,201 · 2
Top collaborators
- Rong Li2 shared
- Jason Yustein2 shared
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Peter J Houghton$32,798,876
- David Steven Libich$2,450,415
- Yu Shin Kim$4,018,851
- Alvaro G Moreira$652,320
- Erich Sohn$77,290
Others in their field
Top investigators on “Doxorubicin”
- Charles A Coltman · Southwest Oncology Group$64,630,528
- Norman Wolmark · Nsabp Foundation, Inc.$52,338,276
- Gregory H Reaman · National Childhood Cancer Foundation$18,332,016
- Laurence H Baker · University Of Michigan At Ann Arbor$12,790,926
- Katherine W Ferrara · Stanford University$10,822,980
- Kit S Lam · University Of California At Davis$10,711,611
Research focus
DoxorubicinAdultChemotherapeutic AgentDna DamageLeadCancer SurvivorCardiotoxicityCellsChemotherapyChildhood Cancer SurvivorLinkMediatingTissuesResponseCardiacCardiac MyocytesBaseAnimal ModelCancer CellAnimalsNovel TherapeuticsMortalityApoptosisApolipoprotein A-I
Grant awards (4)
Mitigating Long-term Cardiotoxicity with Nanoparticle Encapsulated Anthracyclines$197,669
R21 · FY2022 · HL · contact PI
Mitigating Long-term Cardiotoxicity with Nanoparticle Encapsulated Anthracyclines$218,685
R21 · FY2021 · HL · contact PI
BRCA1 and its cofactor in chemotherapy-associated cardiotoxicity$163,788
R21 · FY2016 · CA
BRCA1 and its cofactor in chemotherapy-associated cardiotoxicity$195,059
R21 · FY2015 · CA